Meningococcal Immunisation

20 drugs in development·1 company·7 clinical trials

Drug Pipeline by Phase

Phase 3(14)

Drug	Company
dtap-ipv-hib-hepb vaccine	Sanofi (SNY)
dtwp-hepb-hib-ipv vaccine	Sanofi (SNY)
hepatitis a vaccine	Sanofi (SNY)
human papillomavirus 9-valent vaccine	Sanofi (SNY)
measles vaccine	Sanofi (SNY)
meningococcal (groups a	Sanofi (SNY)
meningococcal group a	Sanofi (SNY)
meningococcal group b vaccine	Sanofi (SNY)
meningococcal polysaccharide (serogroups a	Sanofi (SNY)
meningococcal polysaccharide group a	Sanofi (SNY)
oral bivalent types 1 and 3; poliomyelitis vaccine	Sanofi (SNY)
pneumoccocal vaccine	Sanofi (SNY)
typhoid conjugate vaccine	Sanofi (SNY)
varicella vaccine live	Sanofi (SNY)

Phase 1(2)

Drug	Company
meningococcal group b vaccine menb	Sanofi (SNY)
multicomponent meningococcal b vaccine	Sanofi (SNY)

Phase 1/Phase 2(2)

Drug	Company
menabcyw conjugate vaccine	Sanofi (SNY)
pentavalent meningococcal abcyw vaccine	Sanofi (SNY)

Phase 4(2)

Drug	Company
menacyw conjugate vaccine	Sanofi (SNY)
tetanus toxoid	Sanofi (SNY)

BioSniper tracks 20 drugs in development for Meningococcal Immunisation across 1 company.

There are 7 clinical trials targeting Meningococcal Immunisation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.